Financhill
Buy
92

QFIN Quote, Financials, Valuation and Earnings

Last price:
$47.63
Seasonality move :
16.56%
Day range:
$46.10 - $48.07
52-week range:
$17.76 - $48.50
Dividend yield:
2.53%
P/E ratio:
8.05x
P/S ratio:
3.65x
P/B ratio:
2.19x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
152.79%
Market cap:
$7.2B
Revenue:
$2B
EPS (TTM):
$5.80

QFIN Analysts' Consensus Rating

The 8 analysts providing 12-month price projections for Qifu Technology shares anticipate an average target of $52.77, ranging from a low estimate of $45.42 to a high estimate of $60.00. This average target implies a growth of 10.42% compared to the current stock price of $46.69.

Consensus Price Target

$52.77

Highest Price Target

$60.00

Lowest Price Target

$45.42

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 9 8 8

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

QFIN Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock